
Immgolis: First Interchangeable Biosimilar to Simponi
Analyze the FDA approval of Immgolis (golimumab-sldi), the first interchangeable Simponi biosimilar. Learn how auto-substitution impacts rheumatology care.

Analyze the FDA approval of Immgolis (golimumab-sldi), the first interchangeable Simponi biosimilar. Learn how auto-substitution impacts rheumatology care.
© 2026 IntuitionLabs. All rights reserved.